The clot-dissolving medication, alteplase, improved stroke patients' recovery by more than 50% when given up to 24 hours after the beginning of an ischemic stroke, according to preliminary ...

In a randomized clinical trial in China, giving the clot-busting medication alteplase up to 24 hours after stroke symptoms ...

Use of endovascular thrombectomy in patients with acute ischemic stroke caused by occlusions in distal vessels has failed to ...

Revalesio updates new analyses from phase 2 RESCUE clinical study of RNS60 in patients with acute ischemic stroke: Tacoma, Washington Friday, February 7, 2025, 18:00 Hrs [IST] Rev ...

Wellumio has enrolled the first subject in the Portable MRI study of its magnetic resonance imaging (MRI) device, 'Axana' 0.1T, for stroke identification in emergency department patients. The two-part ...

Hyperfine reports on new data at ISC 2025 showcasing the growing potential for using images from AI-powered portable MRI for ...

Three trials showed no improvement in functional outcomes, and the potential for harm, versus medical therapy alone.

Health professionals at Doncaster and Bassetlaw Teaching Hospitals (DBTH) began the phased transition of urgent, acute, and paediatric services at Bassetlaw Hospital last week, with the process ...

Removing a clot blocking a medium- or small-sized artery in the brain mechanically is a safe treatment for a common type of stroke; however, it did not lessen disability more than best medical ...

A new study found severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was associated with the rapid growth ...